MedTrace Logo

Electrical Stimulation for the Treatment of Glaucoma

NCT05626491 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-04-23

No results posted yet for this study

Summary

The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.

Conditions

Interventions

DEVICE

Repetitive, Transorbital Alternating Current Stimulation (rtACS)

Patients receive treatment every other day via a headband that delivers electrical stimulation to the retina

DEVICE

Sham Repetitive, Transorbital Alternating Current Stimulation (rtACS)

Patients receive sham treatment (no active stimulation) every other day via a headband.

Sponsors & Collaborators

Principal Investigators

  • Jeffrey L Goldberg, MD PhD · Stanford University

  • Bernhard Sable, PhD · Otto-von-Guericke University Magdeburg

  • Joeseph F Panarelli, MD · NYU- Langone

  • Joel Schuman, MD,FACS · Wills Eye

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-28
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Device
Yes

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05626491 on ClinicalTrials.gov